In recent years, our industry has seen a strong emphasis on improved research and drug development in the neuroscience space. Earlier this week, Alector's President and Head of R&D, Sara Kenkare-Mitra PhD, joined industry leaders to discuss the evolving neurodegenerative therapeutic landscape during the #FierceBiotechSummit "Revival in Neuro Therapeutics" panel. Thank you to Fierce Biotech for hosting an impactful event!
Alector
Biotechnology Research
South San Francisco, California 17,940 followers
We are harnessing the immune system to treat neurodegeneration and cancer.
About us
We have always walked our own path at Alector. That’s what led us to our bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery.
- Website
-
http://alector.com
External link for Alector
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Type
- Public Company
- Founded
- 2013
- Specialties
- Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology
Locations
-
Primary
131 Oyster Point Blvd
Suite 600
South San Francisco, California 94080, US
Employees at Alector
Updates
-
#FTD is a devastating disease that remains widely unknown and poorly understood. This #FTDAwarenessWeek, The Association for Frontotemporal Degeneration (AFTD) invited community members to change that through #FoodforThought2024. This grassroots fundraising and awareness campaign focused on food and FTD education. Learn more on their website. https://lnkd.in/gM4ifYdh.
-
Our corporate progress and clinical milestones would not be possible without the collaboration, innovation and adaptability of Alectorians. Our incredible team was strategically built this way - take it from Chief People Officer Clare Hunt (she/her), who has been an invaluable member of our team since 2017. Listen below.
-
Despite an understanding of the potential benefit of supportive resources, about 25% of the caregivers we recently surveyed were unaware of support available for caregivers. There's no shame in seeking support from your community or healthcare providers as a #caregiver. The Association for Frontotemporal Degeneration (AFTD), Family Caregiver Alliance / National Center on Caregiving and Massachusetts General Hospital Frontotemporal Disorders Unit prioritize #FTD caregiver support and education. Check out their pages for more this #FTDAwarenessWeek.
-
Caring for someone living with #FrontotemporalDementia takes incredible dedication. Alector's recent caregiver survey shows that the responsibilities of caregiving take a significant toll on caregivers' abilities to hold careers. It's crucial to recognize the incredibly important work of caregivers this #FTDAwarenessWeek, and always. Learn more at https://lnkd.in/ehnNsZ_p.
-
We recently conducted a survey of 90 primary caregivers of a person diagnosed with #FTD. In honor of #FTDAwarenessWeek, we are committed to educating and advocating for those affected by this devastating disease. The time commitment to caregiving is often greater than, or equal to, a full time job. To learn more, visit https://lnkd.in/ehnNsZ_p.
-
When Chief People Officer Clare Hunt (she/her) joined our team over 7 years ago, Alector was a private, preclinical, start-up company. Since then, she has played an essential role in the growth of our team and expansion of our corporate mission and values. She shares her unique perspective on our culture below.
-
We are pleased to announce the poster presentation at #ISFTD2024 on the baseline characteristics for the global INFRONT-3 Phase 3 clinical trial evaluating the safety and efficacy of our investigational human monoclonal antibody for people with #FTD-GRN. Find more details here. https://lnkd.in/eT-Ym4-w
-
Alector and GSK are proud sponsors of #ISFTD2024. We look forward to joining the International Society for Frontotemporal Dementia (ISFTD) in Amsterdam this week for this impactful event. Find more information here. https://www.isftd2024.org/
-
This September, we stand with Alzheimer's Disease International and those affected by Alzheimer's around the globe during #WorldAlzheimersMonth. This year's theme, "Time to act on dementia, Time to act on Alzheimer’s," focuses on society's view of dementia and the stigma that still exists around the condition. Learn more on ADI's website. https://lnkd.in/eGsXmt4K